Block (XYZ) Form 3 Square / Brian Grassadonia ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Grassadonia Brian

(Last) (First) (Middle)

1455 MARKET STREET

SUITE 600

(Street)

SAN FRANCISCO CA 94103

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
02/13/2020

3. Issuer Name and Ticker or Trading Symbol
Square, Inc. [ SQ ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Cash App Lead

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Class A Common Stock	129,330(1)(2)(3)(4)(5)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	(6)	05/31/2023	Class B Common Stock(7)	3,907	2.904	D
Stock Option (Right to Buy)	(8)	02/27/2024	Class B Common Stock(7)	450,000	7.254	D
Stock Option (Right to Buy)	(9)	06/16/2025	Class B Common Stock(7)	460,000	13.94	D
Stock Option (Right to Buy)	(10)	04/18/2027	Class A Common Stock	137,122	17.2	D
Stock Option (Right to Buy)	(11)	04/24/2028	Class A Common Stock	109,026	44.75	D
Stock Option (Right to Buy)	(12)	04/23/2029	Class A Common Stock	99,224	71.99	D

Explanation of Responses:

1. Represents 2,840 shares of the Issuer's Class A Common Stock owned, 58,007 shares represented by unvested Restricted Stock Awards (RSAs) and 68,483 shares represented by unvested Restricted Stock Units (RSUs).

2. 25,758 of the RSAs represent a contingent right to receive one share of our Class A common stock at the time of grant. Of the original grant of an aggregate of 38,159 RSAs, 1/12th of 10% of the RSAs vested monthly beginning on July 1, 2018 for 12 months, and 1/36th of 90% the remaining RSAs vest monthly thereafter.

3. 32,249 of the RSAs represent a contingent right to receive one share of our Class A common stock at the time of grant. Of the original grant of an aggregate of 39,690 RSAs, 1/16 of the RSAs vested on July 1, 2019, and 1/16 of the total RSAs vest every three months thereafter.

4. 13,205 of the RSUs represent a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement. Of the original grant of an aggregate of 211,268 RSUs, 1/16 of the RSUs vested on July 25, 2016, and 1/16 of the total RSUs vest every three months thereafter.

5. 55,278 of the RSUs represent a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement. Of the original grant of an aggregate of 176,887 RSUs, 1/16 of the RSUs vested on July 1, 2017, and 1/16 of the total RSUs vest every three months thereafter.

6. Of the original grant of an aggregate of 62,500 options, 25% of the shares subject to the option vested on May 20, 2014 and 1/48th of the shares vested monthly thereafter.

7. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder.

8. 20% of the shares subject to the option vested on February 24, 2015 and 1/60th of the shares vested monthly thereafter.

9. 20% of the shares subject to the option vested on June 1, 2016 and 1/60th of the shares vest monthly thereafter.

10. 1/48th of the shares subject to the option vested on May 1, 2017 and 1/48th of the shares vest monthly thereafter.

11. 1/12th of 10% of the shares subject to the option vested monthly beginning on May 1, 2018 for 12 months, and 1/36th of 90% of the shares vest monthly thereafter.

12. 1/48th of the shares subject to the option vested on May 1, 2019 and 1/48th of the shares vest monthly thereafter.

Remarks:

	Shahzia Rahman, Attorney-in-Fact	02/24/2020
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.